AHL
ABBV icon

Abel Hall LLC’s AbbVie ABBV Stock Holding History

Abel Hall LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
7,378
+4,041
+121% +$869K 0.32% 43
2026
Q1 		$726K Buy
3,337
+316
+10% +$70.1K 0.15% 111
2025
Q4 		$690K Buy
3,021
+129
+4% +$29.4K 0.16% 104
2025
Q3 		$670K Buy
2,892
+9
+0.3% +$1.83K 0.27% 54
2025
Q2 		$535K Sell
2,883
-81
-3% -$15.1K 0.25% 71
2025
Q1 		$621K Buy
2,964
+359
+14% +$69.8K 0.37% 43
2024
Q4 		$463K Buy
2,605
+171
+7% +$31.4K 0.3% 53
2024
Q3 		$481K Buy
2,434
+86
+4% +$16.1K 0.31% 50
2024
Q2 		$403K Buy
2,348
+153
+7% +$25.3K 0.28% 57
2024
Q1 		$400K Sell
2,195
-2,047
-48% -$353K 0.3% 53
2023
Q4 		$657K Buy
+4,242
New +$618K 0.56% 28

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Abel Hall LLC's ABBV Position: Q2 2026 in Review

Abel Hall LLC increased its AbbVie (ABBV) stake by 121% in Q2 2026, buying an estimated $869K and bringing the position to 7,378 shares worth $1.86M. The position accounts for 0.32% of the portfolio, ranked #43.

Abel Hall LLC first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,743 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Abel Hall LLC held 7,378 shares of AbbVie worth $1.86M as of Q2 2026.
  • Abel Hall LLC bought 4,041 AbbVie shares in Q2 2026, an estimated $869K.
  • AbbVie made up 0.32% of Abel Hall LLC's portfolio in Q2 2026, its #43 holding.
  • Abel Hall LLC first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,743 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.